gastrointestinal, rheumatic, psychiatric, metabolic, renal, dermatologic, and pulmonary problems, they have been most commonly used for primary and secondary prevention of cardiovascular disease (CVD) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) .
Structure, Sources, and Biosynthesis
Omega-3 fatty acids are a group of poly-unsaturated fatty acids with multiple double bonds, with the first being on the third carbon counting from the methyl end (omega carbon) of the chain (14) . The major types of long chain omega-3 fatty acids include eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) with 20 and 22 carbons, respectively. EPA and DHA are mainly gained from seafood consumption. Small amounts of EPA and DHA can also be synthesized in the body using alpha linolenic acid (ALA), an 18-carbon omega-3 fatty acid found in plants such as flaxseed, canola and walnuts (15) .
Docosapentaenoic acid (DPA) is another long chain omega-3 fatty acid and a metabolite of DHA thought to be formed through the internal metabolic pathways rather than dietary intake.
Molecular and Cellular Effects of Omega-3 Fatty Acids
The composition of lipids in the cell membrane affects multiple cellular functions. Animal studies show that adding omega-3 fatty acids to cell membrane can alter cellular function by interaction with and modulation of membrane channels and proteins; thereby changing the physiochemical properties of cell membrane. Membraneincorporated omega-3 fatty acids might be able to alter membrane protein signaling. Also, the integration of omega-3 fatty acids into cell membrane in animal studies resulted in changes in H-Ras signaling protein and suppressed protein kinase C-theta signaling (15) .
Omega-3 fatty acids exert anti-inflammatory properties through different mechanisms. Some animal studies show that omega-3 fatty acids can suppress the production of interleukin-2 and inhibit lipopolysaccharide-induced inflammation (15) . They also bind to specific nuclear receptors and transcription factors such as PPAR-α, HNF-4α and SREBP-1c that regulate gene expression (15 in activating platelets and triggering vasoconstriction (20) .
However, human trials are not suggestive of a consistent effect on coagulation factors and platelet aggregation, at least for commonly prescribed doses of omega-3 fatty acids (15) .
Omega-3 fatty acids might directly influence heart rate because they can inhibit myocyte voltage-gated sodium channels and prolong the relative refractory period.
Therefore, higher voltages will be required to depolarize the cell membrane and the heart rate will decrease (19) .
Effects on CVD Risk Factors
It is well established that omega-3 fatty acids decrease serum levels of triglycerides, partly through reduced hepatic synthesis of very low-density lipoprotein and partly by boosting the degradation of fatty acids and accelerating triglyceride clearance from the plasma (15, 22) .
With regard to their effects on lipoproteins, randomized controlled trials have yielded mixed results.
Most trials using DHA have shown an increase in lowdensity lipoprotein; while this happened in less than half of the trials using EPA (22) . High-density lipoprotein has been shown to increase in most patients using DHA supplementation; however, the response to EPA supplementation has been variable (22) . 
Mediterranean Diet, Fatty fish and Heart Disease
Large population-based studies have shown that consuming boiled or baked fish, is strongly associated with reduced heart rate and systemic vascular resistance and lower incidence of ischemic heart disease and heart failure (23) (24) (25) .
Dietary guidelines offered by the American Heart
Association recommend the consumption of a variety of fish (preferably oily fish such as salmon, herring, and mackerel) at least twice a week (26) . There is consistent evidence of benefits of fish consumption for cardiovascular health. Modest consumption of fish (e.g. 1-2 servings per week), especially species higher in EPA and DHA is associated with reduced risk of coronary death and total mortality (27) . 
Omega-3 Supplements
Omega-3 products are mostly available as over the counter supplements, but a few such as icosapent ethyl Table 1 . Trials investigating the role of omega-3 supplementation in decreasing cardiovascular events after acute coronary syndromes.
Study

GISSI-Prevenzione Investigators(30)
Galan et al (29) Kromhout et al (31) Rauch et al (32)
In the context of heart failure, a randomized doubleblind placebo-controlled trial in Italy showed a slight decrease in the risk of CVD mortality and hospital admissions due to cardiovascular reasons following daily consumption of 1 gram of omega-3 supplement for a median period of 3.9 years among 3494 patients (33).
However, surprising for a well-designed randomized trial, the study endpoints reached statistically significant differences across the arms only after adjustment for imbalances in baseline characteristics. In other words, it is possible that the presumed basic and clinical benefits of these supplements are less robust than widely thought. However, due to selective reporting, publication bias, or selective citation, positive studies get more popularized. Second, it has been known that improving a risk factor would not necessarily lead to an improvement in hard endpoints such as mortality (42) . In fact, it might be reductionist to consider fatty fish identical 
Financial and Safety Issues
The widespread use of omega-3 supplements implies huge financial expenditure on products of dubious benefits (44) . Furthermore, contrary to the common public belief, supplements are not necessarily devoid of harm (45, 46) .
One potential safety concern with omega-3 supplement use is the risk for hemorrhagic stroke. At very high doses (e.g. showed that in secondary prevention trials cerebrovascular events were more common among participants in the supplement group than the control group (43) .
CONCLUSIONS
Despite the abundance of studies concerning omega-3 supplements, evidence is not clear about the benefits of these supplements, with both positive and negative trials.
One potential challenge over the past several years has been the reporting of positive pieces of evidence by both industry and pro-omega-3 nutritionists/academics while undervaluing the equally robust, if not more robust, negative studies. Also, these products might not be free from risk and the particular risks for bleeding and hemorrhagic stroke deserve further attention.
In summary and in light of the current best evidence, we can conclude that omega-3 supplements might possibly confer cardiovascular benefits but their benefits will be minimal, if any. We are also unsure if there is a subset of patients that would benefit most from this supplementation. Further ongoing investigations could be helpful in that regard. And finally, would the current best evidence lend support to widespread use of omega-3 supplements for primary or secondary CVD prevention?
Our answer given the existing evidence would be "no".
Why not starting with the well-balanced Mediterranean diet, instead?
